Kostman noted, "The 2025 trimming of our supply and demand sources to ensure higher quality will impact our year-over-year comparisons early on," with soft year-over-year performance expected through ...

Good morning, and welcome to the CorMedix Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Leading the call tod ...

NEUTROGUARD study: Phase III clinical study of DEFENCATH for prevention of CLABSI in adults on TPN via central venous catheter.

Q4 2025 Earnings Call March 5, 2026 8:30 AM ESTCompany ParticipantsDavid Kostman - CEO & DirectorJason Kiviat - Chief ...

With me today, I have Omar Asali, our Chairman and CEO, and Bill Drew, our CFO. Omar Asali: Thank you, Sara, and good morning ...

For Indian traders prop firms present a lucrative opportunity to trade with substantial funds offering support through funded ...

Rob will begin his remarks with an update on our business, review our performance against our 2025 priorities, and lay out our 2026 objectives. Then Mark will review the fourth quarter results and ...

Year; Service Revenue of $191.9 million, up 61% Year-over-Year Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp ...

One of the easiest ways to monetize your art or photos is by selling them as prints on Etsy. You don’t need a large budget, ...